263 related articles for article (PubMed ID: 35094410)
1. Concominant bullous pemphigoid and cutaneous Crohn disease.
Cobb CBC; Caravaglio JV; Qureshi AA; Robinson-Bostom L
J Cutan Pathol; 2022 Jun; 49(6):579-583. PubMed ID: 35094410
[TBL] [Abstract][Full Text] [Related]
2. Possible paraneoplastic syndrome case of bullous pemphigoid with immunoglobulin G anti-BP180 C-terminal domain antibodies associated with psoriasis and primary macroglobulinemia.
Maki N; Demitsu T; Umemoto N; Nagashima K; Nakamura T; Kakurai M; Nakamura S; Yamada T; Ishii N; Hashimoto T
J Dermatol; 2016 May; 43(5):571-4. PubMed ID: 26507447
[TBL] [Abstract][Full Text] [Related]
3. Childhood bullous pemphigoid: a clinicopathologic study and review of the literature.
Fisler RE; Saeb M; Liang MG; Howard RM; McKee PH
Am J Dermatopathol; 2003 Jun; 25(3):183-9. PubMed ID: 12775979
[TBL] [Abstract][Full Text] [Related]
4. Bullous Pemphigoid Masquerading as Erythema Annulare Centrifugum.
Yu-Yang S; Chu-Sung Hu S; Yiao-Lin S
Acta Dermatovenerol Croat; 2017 Oct; 25(3):255-256. PubMed ID: 29252183
[TBL] [Abstract][Full Text] [Related]
5. [Bullous pemphigoid, a dermatosis of the elderly].
Hébert V; Joly P
Rev Prat; 2017 Dec; 67(10):1080-1083. PubMed ID: 30512605
[TBL] [Abstract][Full Text] [Related]
6. Insights Into the Pathogenesis of Bullous Pemphigoid: The Role of Complement-Independent Mechanisms.
Cole C; Vinay K; Borradori L; Amber KT
Front Immunol; 2022; 13():912876. PubMed ID: 35874745
[TBL] [Abstract][Full Text] [Related]
7. Respective contribution of neutrophil elastase and matrix metalloproteinase 9 in the degradation of BP180 (type XVII collagen) in human bullous pemphigoid.
Verraes S; Hornebeck W; Polette M; Borradori L; Bernard P
J Invest Dermatol; 2001 Nov; 117(5):1091-6. PubMed ID: 11710917
[TBL] [Abstract][Full Text] [Related]
8. Bullous pemphigoid positive for anti-BP180 and anti-laminin 5 antibodies in a patient with graft-vs-host disease.
Izumi R; Fujimoto M; Yazawa N; Nakashima H; Asashima N; Watanabe R; Kuwano Y; Kurokawa M; Hashimoto T; Tamaki K
J Am Acad Dermatol; 2007 May; 56(5 Suppl):S94-7. PubMed ID: 17434049
[TBL] [Abstract][Full Text] [Related]
9. Biochip detection of BP180 autoantibodies in blister fluid for the serodiagnosis of bullous pemphigoid: A pilot study.
Sernicola A; Russo I; Saponeri A; Alaibac M
Medicine (Baltimore); 2019 Feb; 98(7):e14514. PubMed ID: 30762788
[TBL] [Abstract][Full Text] [Related]
10. IgG antibodies against immunodominant C-terminal epitopes of BP230 do not induce skin blistering in mice.
Feldrihan V; Licarete E; Florea F; Cristea V; Popescu O; Sitaru C; Chiriac MT
Hum Immunol; 2014 Apr; 75(4):354-63. PubMed ID: 24468586
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneity of Brunsting-Perry type pemphigoid: a case showing blister formation at the lamina lucida, immune deposition beneath the lamina densa and autoantibodies against the 290-kD polypeptide along the lamina densa.
Minato H; Ishii N; Fukuda S; Wakasa T; Wakasa K; Sogame R; Hashimoto T; Horiguchi Y
J Dermatol; 2011 Sep; 38(9):887-92. PubMed ID: 21366683
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of histological criteria for bullous pemphigoid. Correlation with antigens recognized by immunoblotting of anti-epidermal autoantibodies].
Courville P; Kupfer I; Gilbert D; Thomine E; Metayer J; Joly P
Ann Pathol; 2000 Dec; 20(6):564-9. PubMed ID: 11148352
[TBL] [Abstract][Full Text] [Related]
13. Antibody to bullous pemphigoid antigen 1 binds to the antigen at perilesional but not uninvolved skin, in localized bullous pemphigoid.
Seishima M; Izumi T; Kitajima Y
Eur J Dermatol; 1999; 9(1):39-42. PubMed ID: 9920986
[TBL] [Abstract][Full Text] [Related]
14. Assessment of Diagnostic Strategy for Early Recognition of Bullous and Nonbullous Variants of Pemphigoid.
Meijer JM; Diercks GFH; de Lang EWG; Pas HH; Jonkman MF
JAMA Dermatol; 2019 Feb; 155(2):158-165. PubMed ID: 30624575
[TBL] [Abstract][Full Text] [Related]
15. Clinical manifestations in 100 Japanese bullous pemphigoid cases in relation to autoantigen profiles.
Tanaka M; Hashimoto T; Dykes PJ; Nishikawa T
Clin Exp Dermatol; 1996 Jan; 21(1):23-7. PubMed ID: 8689764
[TBL] [Abstract][Full Text] [Related]
16. A child with antibodies targeting both linear IgA bullous dermatosis and bullous pemphigoid antigens.
Darling TN; Cardenas AA; Beard JS; Sau P; Yee CL; Zone JJ; Yancey KB
Arch Dermatol; 1995 Dec; 131(12):1438-42. PubMed ID: 7492135
[TBL] [Abstract][Full Text] [Related]
17. A case of bullous pemphigoid with antibodies against intercellular 130 kd antigen.
Takahashi H; Wada T; Matsuo S; Iwatsuki K; Iizuka H
J Dermatol; 1995 Aug; 22(8):576-81. PubMed ID: 7560455
[TBL] [Abstract][Full Text] [Related]
18. Eosinophils, Basophils, and Neutrophils in Bullous Pemphigoid.
Limberg MM; Weihrauch T; Gray N; Ernst N; Hartmann K; Raap U
Biomolecules; 2023 Jun; 13(7):. PubMed ID: 37509055
[TBL] [Abstract][Full Text] [Related]
19. Autoimmune Subepidermal Bullous Diseases of the Skin and Mucosae: Clinical Features, Diagnosis, and Management.
Amber KT; Murrell DF; Schmidt E; Joly P; Borradori L
Clin Rev Allergy Immunol; 2018 Feb; 54(1):26-51. PubMed ID: 28779299
[TBL] [Abstract][Full Text] [Related]
20. Changes in the autoimmune blistering response: a clinical and immunopathological shift from pemphigus foliaceus to bullous pemphigoid.
Maeda JY; Moura AK; Maruta CW; Santi CG; Prisayanh PS; Aoki V
Clin Exp Dermatol; 2006 Sep; 31(5):653-5. PubMed ID: 16901304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
